Ads
related to: alternative treatment for tardive dyskinesia- Access & Support
Comprehensive Support
For Your Patients.
- Differential Diagnosis
Differentiating Between TD
And Drug-Induced Parkinsonism (DIP)
- TD Pivotal Study
See Tardive Dyskinesia Clinical
Trial Results and Learn More.
- TD Long Term Study
Treating TD?
Review the Long Term Study.
- Access & Support
Search results
Results from the WOW.Com Content Network
Deutetrabenazine (trade name Austedo) is a vesicular monoamine transporter 2 inhibitor which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia. Chemically, deutetrabenazine is an isotopic isomer of tetrabenazine in which six hydrogen atoms have been replaced by deuterium atoms.
Tardive dyskinesia (TD) is an iatrogenic disorder that results in involuntary repetitive body movements, which may include grimacing, sticking out the tongue or smacking the lips, [1] which occurs following treatment with medication.
Valbenazine is used to treat tardive dyskinesia in adults. [1] Tardive dyskinesia is a drug-induced neurological injury characterized by involuntary movements. [3] The clinical trials that led to the approval of valbenazine by the US Food and Drug Administration (FDA) were six weeks in duration. [1]
Late-onset dyskinesia, also known as tardive dyskinesia, occurs after long-term treatment with an antipsychotic drug such as haloperidol (Haldol) or amoxapine (Asendin). The symptoms include tremors and writhing movements of the body and limbs, and abnormal movements in the face, mouth, and tongue – including involuntary lip smacking, repetitive pouting of the lips, and tongue protrusions.
Tardive dyskinesia may reverse upon discontinuation of the offending agent or it may be irreversible, withdrawal may also make tardive dyskinesia more severe. [10] Neuroleptic malignant syndrome (NMS) is a rare, but potentially fatal side effect of antipsychotic treatment. NMS is characterized by fever, muscle rigidity, autonomic dysfunction ...
Tiapride is a drug that selectively blocks D 2 and D 3 dopamine receptors in the brain. It is used to treat a variety of neurological and psychiatric disorders including dyskinesia, alcohol withdrawal syndrome, negative symptoms of psychosis, and agitation and aggression in the elderly. [2]
Ads
related to: alternative treatment for tardive dyskinesia